DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases. - Wikidata - awgldk - TriplyDB

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.

http://www.wikidata.org/entity/Q36623924

about

Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment Transcriptional control of cancer metastasis Epigenetic determinants of metastasis Integrated Multiregional Analysis Proposing a New Model of Colorectal Cancer Evolution SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier Prostate cancer epigenetics and its clinical implications Genome-wide predictors of NF-κB recruitment and transcriptional activity Integrative gene set analysis of multi-platform data with sample heterogeneity.Estimating and accounting for tumor purity in the analysis of DNA methylation data from cancer studies Genome-wide DNA methylation measurements in prostate tissues uncovers novel prostate cancer diagnostic biomarkers and transcription factor binding patterns.Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer.Molecular pathways and targets in prostate cancer The role of epithelial plasticity in prostate cancer dissemination and treatment resistance Epigenetic susceptibility factors for prostate cancer with aging.Beyond the androgen receptor: new approaches to treating metastatic prostate cancer. Report of the 2013 Prouts Neck Prostate Cancer Meeting Epigenetic DNA methylation of antioxidative stress regulator NRF2 in human prostate cancer Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.Diagnostic and prognostic utility of a DNA hypermethylated gene signature in prostate cancer.Promoter hypermethylation profiling of distant breast cancer metastases.DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer Dysregulation of the vascular endothelial growth factor and semaphorin ligand-receptor families in prostate cancer metastasis.miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies Global DNA methylation changes and differential gene expression in Anaplasma phagocytophilum-infected human neutrophils.Genomic profiling screens small molecules of metastatic prostate carcinoma.Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression.CellMethy: Identification of a focal concordantly methylated pattern of CpGs revealed wide differences between normal and cancer tissues Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.Intratumoral Heterogeneity of the Epigenome.Perspectives on treatment of metastatic castration-resistant prostate cancer.Epigenetic changes mediated by polycomb repressive complex 2 and E2a are associated with drug resistance in a mouse model of lymphoma.Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes Combined MYC Activation and Pten Loss Are Sufficient to Create Genomic Instability and Lethal Metastatic Prostate Cancer Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer.Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer.Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets.

P2860

Q26783055-1FAD0604-3A5F-4AB9-B5D0-C6970BDA7AFA Q26992024-883472E9-3587-48FB-A1BD-4A1291AD0F97 Q28079377-2165BBDE-F2AC-4572-A9C5-371A703A6AE2 Q28387355-BFC46BE9-71C8-45EE-9018-B67F1146FAB7 Q28550973-459F6497-E835-47CF-9674-04C37E2BFEE3 Q28829460-9EECC41A-5EC0-4974-ACBF-AA26C824988F Q30277994-9BF48F9F-46BB-483E-8DCC-319465FAB606 Q30747009-9D2B3C97-5160-4553-BBBA-725D029814C1 Q31156822-C64371D4-59D7-4568-9682-4EA4A877688C Q33568125-EC365409-8D36-483A-B9BC-C161229F4DC7 Q33784622-DB0E90F9-0699-44DA-80CD-581BAD132B40 Q33920767-B509B2EB-F549-4FB5-B56E-6F8D3285788C Q34183409-78B39B1D-F5AE-4417-B79E-87FE923866A6 Q34365632-6516370A-92B0-4716-ABF5-2C10161C0F4A Q34505037-C122A771-C501-4696-B825-83A32562BCE1 Q34541756-91E38DA3-35A1-4D0B-8503-AC7A3809F3C1 Q34617627-59FCB2F3-1C2C-47E3-AF46-C926CA6738AA Q34633152-C5C88F24-024D-4001-9534-5AB0A7B10FFC Q34701446-177D3041-A437-43D6-8DE4-3769F732F3C5 Q35000853-EDB67203-BC8E-4A7F-8966-8F10163081AD Q35120213-012A6D18-3594-42EA-A3C3-E1344DA9822D Q35533772-8701D9D9-4538-48C4-B0BC-67544DF3B7F2 Q35667011-C568BE6F-57B4-4A6D-A1C1-E2B8E5EAC525 Q35764986-03A9F9AB-D1D5-4EE2-9A74-D3AA5E09C86A Q35897588-F5AB3FDC-A74E-4274-945A-58BB975B6DE4 Q35897966-1D23E345-04F8-42F8-BEFE-67677A7F6A07 Q35900013-290DF16E-5220-4A34-9818-8E62EA7BBF43 Q35944324-B3201FEF-E558-44AE-92CF-CF4B48DF1EF5 Q35956303-FC9AC6AD-0EBF-497C-AF41-22D05C152021 Q36172537-022D24F4-9CE4-444E-9B29-84886B15E493 Q36361273-959012D5-6FFA-47CE-8856-1D3E68CC5962 Q36544611-E113EB12-DD6D-45CB-99E3-DF64EC0EA8DD Q36854908-B5B097D7-7679-401B-B8F7-96B2B669BC83 Q36871685-F5E9944F-03C2-4F6B-984A-0050224A10BF Q36871785-45196EBE-7042-442E-AB37-AFDDE0EC488A Q37110909-2B474686-FCCF-43D3-962A-096E3CCBC7B6 Q37221588-557F83CB-B4C4-4CE0-A36D-9FE199665E7C Q37302524-5538686F-6D0A-4DD3-B8FC-0E084DAEC760 Q37315686-644561AB-4041-415A-ABAD-AF355AE415AA Q37377562-9EE97625-ABC8-4AF2-A154-D7E1BB80DBC0

P2860

DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.

http://www.wikidata.org/entity/Q36623924

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

DNA methylation alterations ex ...... in prostate cancer metastases.

@ast

DNA methylation alterations ex ...... in prostate cancer metastases.

@en

type

label

DNA methylation alterations ex ...... in prostate cancer metastases.

@ast

DNA methylation alterations ex ...... in prostate cancer metastases.

@en

prefLabel

DNA methylation alterations ex ...... in prostate cancer metastases.

@ast

DNA methylation alterations ex ...... in prostate cancer metastases.

@en

P1433

Q36623924-A8914EDE-A582-44EA-802B-63DD444CB6C4

P1476

Q36623924-EAA94576-E6D8-4065-A4E3-1907C41D0C3C

P2093

Q36623924-0A24C798-0F29-4344-AFA4-FF08AB774A48

Q36623924-0E55552A-38D5-4097-8D64-9667467437FD

Q36623924-11EEF1B9-E4D1-4A3A-9798-776810B19603

Q36623924-2736E708-AC04-4BC8-84F3-2B0FD0FE8B2B

Q36623924-2EC910D4-B22C-4572-B068-5B29FDCFBF9E

Q36623924-30069B7C-2B75-44F2-8518-311120183AA5

Q36623924-394479C1-E3C8-4F63-929D-2A82F7EA2DEA

Q36623924-57AAE0A4-C62D-4E99-A15F-C2F3F267A495

Q36623924-73600F15-FC7B-4859-9793-514C537B1044

Q36623924-85E63F48-80F2-434B-BD22-1792F1C9B585

P2860

Q36623924-096ADFB8-3240-474E-BD32-51058597E0CD

Q36623924-0DBECF7F-3ADC-4664-B10C-6A2DB3A902A0

Q36623924-1EFF7F3F-B716-48FA-9EAD-3157A2352259

Q36623924-268BC43D-5AF7-4FB9-B218-10E9796F086F

Q36623924-30AED34B-1192-4AF2-ABC5-35DF876D4BF8

Q36623924-386FB76D-BF48-43F5-B9E5-7EBCDE6FEEFC

Q36623924-3A3AD0D8-6388-4762-94CE-D6FDF01ACDEF

Q36623924-3B0A0D14-F33F-41B6-95FD-C51B4FEF3FE6

Q36623924-3CE5B196-5770-4841-9B04-23D2F9879AC7

Q36623924-3DEE9799-1AD2-4EA1-BF5A-7FEDD7910F90

P304

Q36623924-8BE8F0C9-AE3F-4BCB-8DA5-12BF5DD4A8DB

P31

Q36623924-D4E6F70F-F9C6-4724-90D7-114B267B7364

P356

Q36623924-206A0498-67CC-4AFB-8B90-C5AEB653FB0E

P407

Q36623924-A5577E84-D298-4337-8805-317838B303F5

P433

Q36623924-7FFBC470-470B-49A7-989D-1CB4E7139484

P478

Q36623924-29EDD4C3-B132-43F7-8A86-23FA3F7505CD

P50

Q36623924-9188AF4B-75BB-4C8E-841A-C9A946BEAB6C

P577

Q36623924-34D9C3B3-906E-4515-869C-5EBA569E990B

P5875

Q36623924-24BE6CE8-611C-4592-A632-B33B96034BBC

P698

Q36623924-7B200030-657F-4331-B452-347AC7B45481

P921

Q36623924-37C507C4-64BF-4A61-99F5-8D758237760F

P932

Q36623924-148F8D66-14E8-4167-A7C2-922813A3C959

P356

SCITRANSLMED.3005211

P1433

Science Translational Medicine

P1476

DNA methylation alterations ex ...... in prostate cancer metastases.

@en

P2093

David Esopi

http://www.w3.org/2001/XMLSchema#string

G Steven Bova

http://www.w3.org/2001/XMLSchema#string

Julia C Engelmann

http://www.w3.org/2001/XMLSchema#string

Jun Luo

http://www.w3.org/2001/XMLSchema#string

Martin J Aryee

http://www.w3.org/2001/XMLSchema#string

Meltem Gurel

http://www.w3.org/2001/XMLSchema#string

Michael C Haffner

http://www.w3.org/2001/XMLSchema#string

Philipp Nuhn

http://www.w3.org/2001/XMLSchema#string

Rafael A Irizarry

http://www.w3.org/2001/XMLSchema#string

Robert H Getzenberg

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Role of DNA 5-methylcytosine transferase in cell transformation by fos

Hallmarks of Cancer: The Next Generation

Gene ontology: tool for the unification of biology

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

The genomic complexity of primary human prostate cancer

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Combination of methylated-DNA precipitation and methylation-sensitive restriction enzymes (COMPARE-MS) for the rapid, sensitive and quantitative detection of DNA methylation

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Purification of CpG islands using a methylated DNA binding column

P304

169ra10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3005211

http://www.w3.org/2001/XMLSchema#string

P407

P433

169

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235368161

http://www.w3.org/2001/XMLSchema#string

P698

23345608

http://www.w3.org/2001/XMLSchema#string

P921

DNA methylation

P932

3577373

http://www.w3.org/2001/XMLSchema#string